Occudo Quantitative Strategies’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-4,023
Closed -$17.9K – 673
2024
Q3
$17.9K Sell
4,023
-25
-0.6% -$586 ﹤0.01% 669
2024
Q2
$107K Sell
4,048
-160
-4% -$3.77K 0.02% 660
2024
Q1
$115K Buy
4,208
+2,652
+170% +$84.1K 0.02% 645
2023
Q4
$37.8K Sell
1,556
-546
-26% -$9.68K 0.01% 739
2023
Q3
$42.5K Sell
2,102
-211
-9% -$5.4K 0.01% 916
2023
Q2
$68.2K Sell
2,313
-2,091
-47% -$59.6K 0.01% 952
2023
Q1
$110K Buy
4,404
+305
+7% +$9.82K 0.01% 811
2022
Q4
$130K Buy
4,099
+648
+19% +$20.4K 0.02% 828
2022
Q3
$102K Buy
+3,451
New +$119K 0.01% 1037

Other funds holding LONA

Occudo Quantitative Strategies's LONA Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of LeonaBio Inc (LONA) in Q4 2024, closing a stake of 4,023 shares — an estimated $17.9K sold.

Occudo Quantitative Strategies first reported a position in LONA in Q3 2022 and held it in 9 quarters. The position peaked at $130K in Q4 2022. 56 funds tracked by Wall St. Rank hold LONA as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining LeonaBio Inc position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 4,023 LeonaBio Inc shares in Q4 2024, an estimated $17.9K.
  • Occudo Quantitative Strategies first reported a position in LeonaBio Inc in Q3 2022 and held it in 9 quarters.
  • Occudo Quantitative Strategies's LeonaBio Inc position peaked at $130K in Q4 2022.
  • 56 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.